Zilong Rao

Zilong Rao

Auto-generated profile, based on publicly available information

Zilong Rao

Guangdong Engineering Technology Research Centre for Functional Biomaterials, Key Laboratory for Polymeric Composite & Functional Materials of Ministry of Education, School of Materials Science and Engineering, Sun Yat-sen University, Guangzhou, 510006, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2024 in Acta Biomaterialia
Verified
Journal Article
Closed access
ZLZelin Liang
Zelin Liang
JLJunda Li
Junda Li
HLHongkun Lin
Hongkun Lin
SZSien Zhang
Sien Zhang
FLFan Liu
Fan Liu
QHQiting Huang
Qiting Huang

18 December 2023 in Applied Surface Science
Verified
Journal Article
Closed access
JHJiandong Han
Jiandong Han
KZKexin Zhang
Kexin Zhang
ZRZilong Rao
Zilong Rao
JCJiaxin Chen
Jiaxin Chen
YMYue Meng
Yue Meng
YBYing Bai
Ying Bai

2 January 2024 in Regenerative Biomaterials
Verified
Journal Article
Open access
PDF file
YXYuan Xia
Yuan Xia
ZRZilong Rao
Zilong Rao
SWSimin Wu
Simin Wu
JHJiayao Huang
Jiayao Huang
HZHaiyun Zhou
Haiyun Zhou
YLYunqi Liu
Yunqi Liu
Coronary artery bypass grafting is acknowledged as a major clinical approach for treatment of severe coronary artery atherosclerotic heart disease. This procedure typically requires autologous small-diameter vascular grafts. However, the limited availability of the donor vessels and associated trauma during tissue harvest underscore the necessity for artificial arterial alternatives. Herein, decellularized bovine intercostal arteries were successfully fabricated with lengths ranging from 15 to 30 cm, which also closely match the inner diameters of human coronary arteries. These decellularized arterial grafts exhibited great promise following poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) grafting from the inner surface. Such surface modification endowed the decellularized arteries with superior mechanical strength, enhanced anticoagulant properties and improved biocompatibility, compared to the decellularized bovine intercostal arteries alone, or even those decellularized grafts modified with both heparin and vascular endothelial growth factor. After replacement of the carotid arteries in rabbits, all surface-modified vascular grafts have shown good patency within 30 days post-implantation. Notably, strong signal was observed after α-SMA immunofluorescence staining on the PMPC-grafted vessels, indicating significant potential for regenerating the vascular smooth muscle layer and thereby restoring full structures of the artery. Consequently, the decellularized bovine intercostal arteries surface modified by PMPC can emerge as a potent candidate for small-diameter artificial blood vessels, and have shown great promise to serve as viable substitutes of arterial autografts.

13 August 2025 in Small
Verified
Journal Article
Closed access
ZRZilong Rao
Zilong Rao
QHQiting Huang
Qiting Huang
YJYifei Jiang
Yifei Jiang
ZLZudong Lin
Zudong Lin
SQShuai Qiu
Shuai Qiu
YBYing Bai
Ying Bai

22 January 2026 in Regenerative Biomaterials
Verified
Journal Article
Open access
PDF file
FHFulin He
Fulin He
ZLZhenpeng Li
Zhenpeng Li
FLFawei Liao
Fawei Liao
SWShuihuan Wang
Shuihuan Wang
XHXijun Huang
Xijun Huang
SQShuai Qiu
Shuai Qiu
Building upon the clinically established platform of acellular nerve allografts (ANAs), we developed an advanced derivative: acellular nerve perineurium (ANP) grafts. These grafts are characterized by their preservation of the native perineurial barrier architecture and a unique extracellular matrix (ECM) composition, distinct from the endoneurial basement membrane. This distinctive ECM profile endows ANPs with significantly enhanced barrier integrity and robust neuroprotective properties. In vitro evaluations confirmed that ANP provides a highly favorable substrate, effectively supporting the adhesion and active proliferation of dorsal root ganglion neurons. In a rat model of sciatic nerve transection, ANP grafts demonstrated remarkable therapeutic efficacy. They markedly inhibited the deposition of chondroitin sulfate proteoglycans (CSPGs) at the repair site, thereby preventing traumatic neuroma formation. Furthermore, ANP treatment resulted in a doubling of regenerated axon density and a significant increase in target muscle action potential amplitude. Behavioral recovery in ANP-treated animals approached the functional levels observed in crush-injury controls. Multiomics analyses provided mechanistic insight, revealing that ANP-mediated repair activates multiple pro-regenerative signaling pathways. These collective findings position ANP grafts as a highly promising and clinically translatable biomaterial strategy for improving functional outcomes in peripheral nerve repair.

28 May 2026 in Materials Today Bio
Verified
Journal Article
Open access
SZShengwen Zhu
Shengwen Zhu
RCRui Cui
Rui Cui
SQShuai Qiu
Shuai Qiu
XZXi Zhang
Xi Zhang
JMJingxin Ma
Jingxin Ma
YBYing Bai
Ying Bai
Peripheral nerve injury (PNI), especially those with long-distance transected defects, remains a major clinical challenge due to limited regenerative capacity associated with inadequate endogenous Schwann cell (SC) support. Here, we developed a biomimetic nerve graft with a defined spatial gradient of immobilized SCs to facilitate effective transplantation and axonal guidance, thus enhancing peripheral nerve regeneration. SCs were initially encapsulated within decellularized nerve matrix (DNM) microgels using a customized flow-focusing microfluidic device. The DNM microgels supported good viability, facilitated cellular proliferation, and preserved the repair phenotype of the encapsulated SCs, while maintaining their advantageous paracrine activity conducive to axon extension. Furthermore, these microgels were incorporated into the density-gradient pores of a pre-designed scaffold, resulting in a gradient SC-laden scaffold, designated as MGs@G-scaffold. Notably, the spatially graded SCs within the MGs@G-scaffold created a stable environmental gradient of neurotrophic factors, thereby providing sustained biochemical cues to guide axonal elongation. Finally, when transplanted into a 15-mm rat sciatic nerve defect model, the SC-laden scaffolds exhibited significantly improved axonal regeneration, remyelination, and functional recovery compared with the SC-free scaffolds. Additionally, MGs@G-scaffolds outperformed scaffolds with uniform SC distribution (MGs@H-scaffolds), achieving therapeutic outcomes comparable to autografts. Overall, this study demonstrates that transplanting spatially graded SCs embedded in a tissue-engineered bioactive scaffold offers sustained ongoing support for cells, gradient biochemical signals, and a pro-regenerative microenvironment for nerve regeneration and functional recovery, which holds great promise for long-distance PNI repair.